Comparative Analysis of Antioxidant, Anticholinesterase, and Antibacterial Activity of Microbial Chondroitin Sulfate and Commercial Chondroitin Sulfate

Basit Öğe Kaydı
dc.authoridbingul, murat/0000-0002-3909-0694
dc.authoridUnver, Tuba/0000-0002-8655-2716
dc.authoridBoga, Mehmet/0000-0003-4163-9962
dc.authorwosidbingul, murat/HGE-0682-2022
dc.authorwosidUnver, Tuba/ABI-6440-2020
dc.contributor.authorUnver, Tuba
dc.contributor.authorErenler, Ayse Sebnem
dc.contributor.authorBingul, Murat
dc.contributor.authorBoga, Mehmet
dc.date.accessioned2024-08-04T20:54:40Z
dc.date.available2024-08-04T20:54:40Z
dc.date.issued2023
dc.departmentİnönü Üniversitesien_US
dc.description.abstractChondroitin synthesis was performed using the recombinant Escherichia coli(C2987) strain created by transforming the plasmid pETM6-PACF-vgb, which carries the genes responsible for chondroitin synthesis, kfoA, kfoC, kfoF, and the Vitreoscilla hemoglobin gene (vgb). Then, Microbial chondroitin sulfate (MCS)'s antioxidant, anticholinesterase, and antibacterial activity were compared with commercial chondroitin sulfate (CCS). The antioxidant studies revealed that the MCS and CCS samples could be potential targets for scavenging radicals and cupric ion reduction. MCS demonstrated better antioxidant properties in the ABTS assay with the IC50 value of 0.66 mg than CCS. MCS showed 2.5-fold for DPPH and almost 5-fold for ABTS *+ (with a value of 3.85 mg/mL) better activity than the CCS. However, the compounds were not active for cholinesterase enzyme inhibitions. In the antibacterial assay, the Minimum inhibitory concentration (MIC) values of MCS against S. aureus, E. aerogenes, E. coli, P. aeruginosa, and K. pneumoniae (0.12, 0.18, 0.12, 0.18, and 0.18 g/mL, respectively) were found to be greater than that of CCS (0.42, 0.48, 0.36, 0.36, and 0.36 g/mL, respectively). This study demonstrates that MCS is a potent pharmacological agent due to its physicochemical properties, and its usability as a therapeutic-preventive agent will shed light on future studies.en_US
dc.description.sponsorshipWe would like to thank Wenqin He, Mattheos A.G. Koffas, and the entire research team who produced the pETM6-PACF plasmid and shared it without hesitation.en_US
dc.description.sponsorshipWe would like to thank Wenqin He, Mattheos A.G. Koffas, and the entire research team who produced the pETM6-PACF plasmid and shared it without hesitation.en_US
dc.identifier.doi10.1002/cbdv.202300924
dc.identifier.issn1612-1872
dc.identifier.issn1612-1880
dc.identifier.pmid37615364en_US
dc.identifier.scopus2-s2.0-85170055312en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.urihttps://doi.org/10.1002/cbdv.202300924
dc.identifier.urihttps://hdl.handle.net/11616/101562
dc.identifier.wosWOS:001060373100001en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWiley-V C H Verlag Gmbhen_US
dc.relation.ispartofChemistry & Biodiversityen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectanimal-originated chondroitin sulfateen_US
dc.subjectantibacterial activityen_US
dc.subjectanticholinesterase activityen_US
dc.subjectantioxidant agenten_US
dc.subjectmicrobial chondroitin sulfateen_US
dc.titleComparative Analysis of Antioxidant, Anticholinesterase, and Antibacterial Activity of Microbial Chondroitin Sulfate and Commercial Chondroitin Sulfateen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu